The increased risk of severe illness from influenza among older adults is well known, with almost 90% of annual influenza-associated deaths occurring among adults aged ≥65 years [1] . This burden is compounded by the significantly reduced efficacy of inactivated influenza vaccine in older adults, particularly those aged ≥70 years or with decreased functional status [2, 3] . Outbreaks of influenza among residents in long-term care facilities (LTCFs) are well documented, even in the setting of high vaccination rates [4, 5] . Additional strategies are clearly needed to prevent influenza in these high-risk populations. In this issue of The Journal of Infectious Diseases, Nace et al present results from an immunogenicity study of high-dose (HD) influenza vaccine in a sample of frail, elderly residents of LTCFs. This study complements earlier work by DiazGranados et al, who demonstrated superior immunogenicity and superior clinical efficacy against laboratoryconfirmed influenza of the HD influenza vaccine, compared with the standarddose influenza vaccine, in communitydwelling persons aged ≥65 years [6] .
Immune senescence is associated with decreased vaccine immune responses among healthy adults aged ≥65 years, and differences in frailty (as measured by ability to live unassisted or other factors) may significantly impact the benefit of influenza vaccination in preventing influenza-related illness and death [2, 3, 7] . The development of more-immunogenic vaccines, including HD influenza vaccines, aims to address both of these problems, but confirmatory studies documenting the clinical impact of HD vaccine and the superiority of HD over standard-dose vaccine in preventing influenza among LTCF residents are not yet available. Although the study by Nace et al provides some evidence of improved immunogenicity of HD over standarddose vaccine among LTCF residents, overall titers even after HD vaccination are modest at best and are far below titers reported among community-dwelling older adults following HD influenza vaccination [6] .
LTCFs concentrate large numbers of frail older adults in relatively closed areas, increasing both the likelihood and potential harm of influenza outbreaks. Attack rates of >20% during influenza outbreaks have been reported, even among wellvaccinated populations of LTCF residents [4, 8] . The Centers for Disease Control and Prevention (CDC) recommends active surveillance for respiratory disease outbreaks in LTCFs and testing when influenza is suspected as the cause of an outbreak. Administration of influenza antiviral medications for treatment of ill residents and prophylaxis of unaffected residents, use of standard and droplet precautions by healthcare personnel (HCP) in the facility, and social-distancing measures such as isolation of ill residents, limiting group activities and restricting visitors to the facility, and ensuring HCP do not move between affected and unaffected areas of the facility are further recommended to reduce the impact of influenza during outbreaks [9] . Rapid implementation of recommended control measures can reduce the number of secondary influenza cases and limit the size of outbreaks, whereas lack of control measures can result in high rates of illness, hospitalization, and death in frail residents of LTCFs [4, 5, 9] .
Although far from perfect, annual influenza vaccination of both residents and HCP remains one of the most important measures available to reduce the risk of influenza and its complications in LTCFs. Given the considerable risk of influenza complications and death among LTCF residents in particular, even partial protection against the sequelae of influenza virus infection is an outcome to be highly valued. However, vaccination of LTCF residents alone is not sufficient. Vaccination of HCP who work in LTCFs is critical to reduce the risk of introducing influenza into the LTCF. Findings from multiple studies indicate that influenza vaccination of HCP lowers the risk of death among LTCF residents [10] . In general, HCP are younger and healthier than LTCF residents and are, therefore, likely to have superior immune responses to seasonal influenza vaccination; studies support the effectiveness of influenza vaccination in reducing the incidence of confirmed influenza among healthy adults [11] . Despite evidence of the benefits of HCP vaccination in reducing the risk of mortality among LTCF residents and long-standing CDC recommendations to vaccinate all HCP, vaccination rates among HCP working in LTCFs are far from optimal and are notably lower than rates for HCP working in other healthcare settings: for the 2013-2014 influenza season, 63% of HCP working in LTCFs reported influenza vaccination, compared with 74% of HCP working in ambulatory care settings or physician offices and with nearly 90% of HCP working in hospitals [12] .
Nace et al note several potential challenges to conducting a clinical trial among LTCF residents to examine the clinical benefit of HD versus standard-dose influenza vaccination to prevent influenza and its complications. However, several cluster-randomized trials in LTCFs that included influenza surveillance among LTCF residents have been successfully conducted to study the effects of HCP influenza vaccination on LTCF residents [10] . Similar trials focused on vaccination of LTCF residents would provide muchneeded information about the relative benefits of HD versus standard-dose vaccine for preventing influenza in this frail group. In the interim, LTCFs should focus efforts on ensuring influenza vaccination of residents, improving the suboptimal influenza vaccination rates among HCP in LTCFs, and ensuring that LTCF staff are prepared to detect and mitigate influenza outbreaks among LTCF residents when outbreaks do occur. 
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